Pulmonx shares surge 25.78% after-hours after closing $60M credit facility and unveiling Chartis Precision XL catheter.

Pulmonx surged 25.78% in after-hours trading following the announcement of two key developments. The company closed a $60 million credit facility, providing liquidity to support growth initiatives, and introduced the Chartis Precision XL catheter, a next-generation tool enhancing diagnostic precision in pulmonary procedures. The product launch, showcased at an industry event, underscores Pulmonx’s innovation strategy in respiratory care. Both events—securing capital and advancing its product portfolio—likely drove investor optimism, aligning with the sharp post-market price increase.